The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women.
Adding Tucatinib to T-DM1 Shows PFS Benefit in HER2-Positive Breast Cancer
Findings from the phase III HER2CLIMB-02 trial presented at the San Antonio Breast Cancer Symposium showed that the addition of tucatinib (Tukysa) to trastuzumab emtansine
December 23, 2023